Download FREE Report Sample
Download Free sampleHereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR). Mutations in the gene for TTR frequently result in instability of TTR and subsequent fibril formation. HATTR can be sub-classified into familial amyloid polyneuropathy (FAP) and familial amyloid cardiomyopathy (FAC). The deposition of TTR amyloid fibrils in various tissues leads to ATTR, including Familial ATTR (hereditary ATTR) and non-hereditary ATTR types. Familial ATTR is a rare disorder with unequal distribution all around the world.
Hereditary Transthyretin Amyloidosis Market contains market size and forecasts of Hereditary Transthyretin Amyloidosis (HATTR) in Global, including the following market information:
The global Hereditary Transthyretin Amyloidosis (HATTR) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hereditary Transthyretin Amyloidosis (HATTR) include Pfizer, Alnylam Pharmaceuticals, Akcea Therapeutics, Prothena, Lonis Pharmaceuticals, Eidos Therapeutics and Corino Therapeutics Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hereditary Transthyretin Amyloidosis (HATTR) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Transthyretin Amyloidosis (HATTR) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, by Type, 2021 (%)
Global Hereditary Transthyretin Amyloidosis (HATTR) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, by Application, 2021 (%)
Global Hereditary Transthyretin Amyloidosis (HATTR) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
